Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Co-prenozide 160mg/0.25mg modified-release tablets |
| BNF code | 0204000Y0AAAAAA |
| Virtual Therapeutic Moiety | Co-prenozide |
| Date identifier became valid | 31 Oct 2018 |
| Previous product identifier | 318583001 |
| Basis of preferred name | BAN - British Approved Name |
| Date of name applicability | 4 May 2004 |
| Previous name | Co-prenozide 160/0.25 modified-release tablets |
| Basis of previous name | BAN - British Approved Name |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products not Available |
| Non-availability status date | 25 Jan 2012 |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Oxprenolol hydrochloride |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 160.000 |
| Strength value numerator unit | mg |
| Virtual Product Ingredient | |
| Ingredient | Cyclopenthiazide |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 250.000 |
| Strength value numerator unit | microgram |
| Ontology Drug Form & Route | |
| Form & Route | tabletmodified-release.oral |
| Dose Form | |
| Formulation | Modified-release tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Virtual Medicinal Product Packs | |
| Co-prenozide 160mg/0.25mg modified-release tablets 28 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.